Timber
is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of dermatologic diseases... Read moreTimber
is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of dermatologic diseases... Read more
News
Aug 22, 2024
Clinical Trials Arena
Timber: Leo Pharma's Timber bet falls flat following Phase III failure
Aug 21, 2024
Endpoints News
Timber: Timber Pharmaceuticals' candidate for rare skin disorder flunks all endpoints in late-stage trial
Mar 10, 2024
Acrofan
Timber: Timber Pharmaceuticals, Inc., a LEO Pharma Company, Presents Late-Breaking Preliminary Results of TMB-001 in Moderate-to-Severe Congenital Ichthyosis
Feb 13, 2024
Global Legal Chronicle
Timber: Timber Pharmaceuticals' Chapter 11 and Asset Sale to Leo Pharma
Feb 13, 2024
Global Legal Chronicle
Timber: Timber Pharmaceuticals' Chapter 11 and Asset Sale to Leo Pharma.
Jan 22, 2024
Acrofan
Timber: LEO Pharma Finalizes Acquisition of Key Assets From Timber Pharmaceuticals
Nov 30, 2023
ABF Journal
Timber: Timber Pharmaceuticals Receives Court Approval of All "First Day" Motions
Nov 29, 2023
BioSpace
Timber: Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
Nov 20, 2023
Beckers Hospital Review
Timber: Timber Pharmaceuticals files for bankruptcy
Sep 18, 2023
MarketScreener
Timber: Timber Pharmaceuticals : Announces NYSE Acceptance of Plan to Regain Listing Compliance - Form 8-K
Timber Competitors
1
2
3
4
5
6
7
8
9
10